Applications Claiming Priority (3) Publications (3) Family ID=22690836 Family Applications (1) Country Status (7) Families Citing this family (22) Family Cites Families (11) 1988 1988-04-29 US US07/187,870 patent/US4883672A/en not_active Expired - Lifetime 1989 1989-04-27 CA CA000597946A patent/CA1336505C/en not_active Expired - Lifetime 1989-04-28 EP EP89905904A patent/EP0365664B1/en not_active Expired - Lifetime 1989-04-28 DE DE68922064T patent/DE68922064T2/en not_active Expired - Lifetime 1989-04-28 JP JP1505924A patent/JP2926820B2/en not_active Expired - Lifetime 1989-04-28 WO PCT/US1989/001808 patent/WO1989010065A1/en not_active Ceased 1989-04-28 AU AU35714/89A patent/AU640610B2/en not_active Expired
TABLE 4 Pharmacologically underexploited peptides mediating bonemusclefat endocrine crosstalk: native peptide biology underdeveloped as therapeutic targets
Comprehensive nutritional support : Each serving contains 24g of high-quality protein (whey or pea options), 1B CFU of probiotics, psyllium husk fiber, 15 essential vitamins and minerals, and an optimal ratio of electrolytes
- BPC 157: Science-Backed Uses, Benefits, Dosage, and Safety - BPC-157 Side Effects and Safety: What You Need to Know Before
Most are administered via subcutaneous injection, though oral semaglutide (Rybelsus) is also available
Homogenates of stomachs were used to evaluate endogenous antioxidant enzyme activities
